Bone regeneration using photocrosslinked hydrogel incorporating rhBMP-2 loaded 2-N, 6-O-sulfated chitosan nanoparticles.

[1]  W. Virkus,et al.  Healing of rat femoral segmental defect with bone morphogenetic protein-2: a dose response study. , 2012, Journal of musculoskeletal & neuronal interactions.

[2]  Xinqiao Jia,et al.  Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. , 2011, Acta biomaterialia.

[3]  Emil H Schemitsch,et al.  Growth factors and bone regeneration: how much bone can we expect? , 2011, Injury.

[4]  M. Gümüşderelioğlu,et al.  Heparin-functionalized chitosan scaffolds for bone tissue engineering. , 2011, Carbohydrate research.

[5]  P. Carmeliet,et al.  3D systems delivering VEGF to promote angiogenesis for tissue engineering. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Eyal Zussman,et al.  Slow-release human recombinant bone morphogenetic protein-2 embedded within electrospun scaffolds for regeneration of bone defect: in vitro and in vivo evaluation. , 2011, Tissue engineering. Part A.

[7]  Seong Soo Kang,et al.  Enhanced regeneration of the ligament-bone interface using a poly(L-lactide-co-ε-caprolactone) scaffold with local delivery of cells/BMP-2 using a heparin-based hydrogel. , 2011, Acta biomaterialia.

[8]  Misook Kim,et al.  A highly elastic tissue sealant based on photopolymerised gelatin. , 2010, Biomaterials.

[9]  Yu-Chen Hu,et al.  The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. , 2010, Biomaterials.

[10]  G. Edwards,et al.  Evaluation of photo-crosslinked fibrinogen as a rapid and strong tissue adhesive. , 2009, Journal of biomedical materials research. Part A.

[11]  P. Choong,et al.  The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model. , 2010, Biomaterials.

[12]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery , 2009, Biotechnology Letters.

[13]  Timothy C. Hughes,et al.  The development of photochemically crosslinked native fibrinogen as a rapidly formed and mechanically strong surgical tissue sealant. , 2009, Biomaterials.

[14]  Yen Chang,et al.  A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs. , 2009, Biomaterials.

[15]  Changsheng Liu,et al.  Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. , 2009, Biomaterials.

[16]  S. Bohic,et al.  The in vivo degradation of a ruthenium labelled polysaccharide-based hydrogel for bone tissue engineering. , 2009, Biomaterials.

[17]  Y. Tabata,et al.  BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. , 2009, Bio-medical materials and engineering.

[18]  Bai-Shuan Liu,et al.  Fabrication and evaluation of a biodegradable proanthocyanidin-crosslinked gelatin conduit in peripheral nerve repair. , 2008, Journal of biomedical materials research. Part A.

[19]  J. Jansen,et al.  The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. , 2008, Journal of biomedical materials research. Part A.

[20]  W. Hennink,et al.  In situ gelling hydrogels for pharmaceutical and biomedical applications. , 2008, International journal of pharmaceutics.

[21]  Evaluation of gelatin/resorcinol/aldehyde as a hemostatic agent and tissue adhesive: an experimental study in rat. , 2008, International surgery.

[22]  Wei Wei,et al.  A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system. , 2007, Biomaterials.

[23]  M. Amiji,et al.  Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[24]  G. Ciardelli,et al.  Transglutaminase Reactivity with Gelatine: Perspective Applications in Tissue Engineering , 2006, Biotechnology Letters.

[25]  S. Glassman,et al.  Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.

[26]  T. Vuocolo,et al.  Synthesis and properties of crosslinked recombinant pro-resilin , 2005, Nature.

[27]  Asmita Banerjee,et al.  Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. , 2005, The Annals of thoracic surgery.

[28]  R. Leblanc,et al.  Nitrocinnamate-functionalized gelatin: synthesis and "smart"hydrogel formation via photo-cross-linking. , 2005, Biomacromolecules.

[29]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[30]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[31]  W. Bubnis,et al.  Chemical and Swelling Evaluations of Amino Group Crosslinking in Gelatin and Modified Gelatin Matrices , 1996, Pharmaceutical Research.

[32]  R. Kamijo,et al.  Sulfated Polysaccharides Enhance the Biological Activities of Bone Morphogenetic Proteins* , 2003, Journal of Biological Chemistry.

[33]  Gregory F Payne,et al.  Enzyme-catalyzed gel formation of gelatin and chitosan: potential for in situ applications. , 2003, Biomaterials.

[34]  J. van den Dolder,et al.  Observations on the effect of BMP-2 on rat bone marrow cells cultured on titanium substrates of different roughness. , 2003, Biomaterials.

[35]  A. Bigi,et al.  Stabilization of gelatin films by crosslinking with genipin. , 2002, Biomaterials.

[36]  Dietmar W. Hutmacher,et al.  Preliminary study on the adhesion and proliferation of human osteoblasts on starch-based scaffolds , 2002 .

[37]  S. Papapoulos,et al.  Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A. , 2002, Endocrinology.

[38]  K. Ulubayram,et al.  Cytotoxicity evaluation of gelatin sponges prepared with different cross-linking agents , 2002, Journal of biomaterials science. Polymer edition.

[39]  A. Bigi,et al.  Mechanical and thermal properties of gelatin films at different degrees of glutaraldehyde crosslinking. , 2001, Biomaterials.

[40]  J. Wozney,et al.  rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of in Vitro Sponge Characteristics and Protein pI on in Vivo rhBMP Pharmacokinetics , 1999, Annals of the New York Academy of Sciences.

[41]  T. Kodadek,et al.  Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Y. Ikada,et al.  Cross-linking of gelatin with carbodiimides. , 1996, Tissue engineering.

[43]  V. Shah,et al.  Cross‐Linking of Gelatin Capsules and Its Relevance to Their in vitro‐ in vivo Performance , 1995 .

[44]  F. Chertok,et al.  Novel materials from protein–polymer grafts , 1987, Nature.

[45]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.